Kennedy Jr. and the members of his newly appointed vaccine panel are casting doubt on the hepatitis B vaccine and the ...

At the crossroads of public health innovation and compassionate care stands Dr. Sharon Karbo, a physician, researcher, and health strategist whose work is quietly reshaping health systems in Ghana and ...

GSK’s antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval, said the drugmaker this morning.

A research team from Bochum and Hannover shows that the hepatitis E virus also attacks organs other than the liver.